Clive Morris's most recent trade in Neogenomics Inc. was a trade of 30,572 Common Stock done . Disclosure was reported to the exchange on Dec. 30, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Clive Morris | President of Inivata | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2021 | 30,572 | 41,280 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Clive Morris | President of Inivata | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 53,857 | 53,857 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Clive Morris | President of Inivata | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 10,708 | 10,708 (0%) | 0% | 0 | Common Stock |